Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 124

Sort by

Sort Order Select

Journal Articles

Evaluation of Virus-Specific T Cell Responses in Patients Affected with Myeloproliferative Neoplasms Treated with Ruxolitinib

Elisa Rumi, MD, Chiara Cavalloni, MD, Giuditta Comolli, Virginia Valeria Ferretti, Irene Cassaniti, Daniela Pietra, PhD, Chiara Trotti, MD, Michele Ciboddo, MD, Melania Degli Antoni, Milena Furione, Fausto Baldanti, MD, Luca Arcaini, Mario Cazzola, MD

Blood (2019) 134 (Supplement_1): 1660.

https://doi.org/10.1182/blood-2019-127994

Published: 2019

Journal Articles

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Debora Basilio Basilio-Queiros, MSc, Susanne Luther, Arnold Ganser, MD, Eva M Weissinger, MD

Blood (2019) 134 (Supplement_1): 1939.

https://doi.org/10.1182/blood-2019-121914

Published: 2019

Journal Articles

Repertoire of Cytomegalovirus-Specific T Cells Is Focused on the Immunodominant Epitopes in Fixed Hierarchy Dependent on HLA Genotype of the Donor

Alexandra Vladimirovna Maleeva, MSc, Vyacheslav Anatolevich Shmarov, Dmitry Olegovych Kiryukhin, Grigory Aleksandrovich Efimov, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 2327.

https://doi.org/10.1182/blood-2019-130241

Published: 2019

Journal Articles

Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR)

Elisa Gabanti, Roberta Sciarra, MD, Oscar Borsani, MD, Giuseppe Gerna, Daniela Caldera, MD, Anna Amelia Colombo, MD, Emilio Paolo Alessandrino, MD, Paolo Bernasconi, MD, Daniele Lilleri

Blood (2019) 134 (Supplement_1): 4544.

https://doi.org/10.1182/blood-2019-129939

Published: 2019

Journal Articles

Reduced Expression of the CD94/NKG2C NK Cell Receptor in Chronic Lymphocytic Leukemia (CLL) and CLL-like Monoclonal B-Cell Lymphocytosis (MBL)

Anna Puiggros, PhD, Gonzalo Blanco, PhD, Aura Muntasell, María Rodríguez-Rivera, Lara Nonell, Eulalia Puigdecanet, Magdalena Arnal, Xavier Calvo, MD PhD, Eva Gimeno, MD PhD, Eugenia Abella, Pau Abrisqueta, MD PhD, Francesc Bosch, MD PhD, José Yélamos, Ana Ferrer, MD PhD, Miguel Lopez-Botet, Blanca Espinet, PhD

Blood (2019) 134 (Supplement_1): 5457.

https://doi.org/10.1182/blood-2019-128055

Published: 2019

Journal Articles

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

Moritz Bewarder, MD, Gerhard Held, MD, Lorenz Thurner, MD, Klaus Dieter Preuss, PhD, Gabi Carbon, Birgit Bette, Konstantinos Christofyllakis, MD, Arne Felbel, Dominic Kaddu-Mulindwa, MD, Niels Murawski, MD, Stephan Stilgenbauer, Frank Neumann, PhD

Blood (2019) 134 (Supplement_1): 5616.

https://doi.org/10.1182/blood-2019-126998

Published: 2019

Journal Articles

Comparing Costs Associated to Letermovir Prophylaxis Vs Ganciclovir Pre-Emptive Therapy in HCMV-Seropositive Patients Who Undergone to Hemopoietic Stem Cells Transplantation

Oscar Borsani, MD, Daniele Lilleri, Elisa Gabanti, Gabriela Cassinelli, Anna Amelia Colombo, MD, Daniela Caldera, MD, Emilio Paolo Alessandrino, MD, Paolo Bernasconi, MD

Blood (2019) 134 (Supplement_1): 5643.

https://doi.org/10.1182/blood-2019-124121

Published: 2019

Journal Articles

Cytomegalovirus Infection in Bone Marrow-Derived Mesenchymal Stem Cells: Implications for Functions and Exploration of Relevant Mechanisms

Weiran Lv, Zhiping Fan, MD, Fen Huang, MD, Na Xu, MD, Li Xuan, MD, Ren Lin, MD, Ke Zhao, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 5005.

https://doi.org/10.1182/blood-2019-125318

Published: 2019

Journal Articles

Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

Xingxing Yu, Xiangyu Zhao, Xunhong Cao, Xuefei Liu, Xuying Pei, PhD, Xiaosu Zhao, Ying-Jun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, MD PhD, Xiao Jun Huang

Blood (2018) 132 (Supplement 1): 360.

https://doi.org/10.1182/blood-2018-99-115772

Published: 2018

Journal Articles

First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation

Xiangyu Zhao, Xuying Pei, PhD, Xiaojun Huang, Ying-Jun Chang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, MD PhD

Blood (2018) 132 (Supplement 1): 727.

https://doi.org/10.1182/blood-2018-99-113923

Published: 2018

Journal Articles

Early Cytomegalovirus Reactivation and Donor Constellation Reduce Early and Late Relapse Incidence of Acute Myeloid Leukemia in a Long-Term Study

Amin T. Turki, MD PhD, Nikolaos Tsachakis-Mück, Saskia Leserer, Ji-Hee Yi, MD, Evren Bayraktar, PhD, Rashit Bogdanov, Tobias Liebregts, Nina Kristin Steckel, Melanie Fiedler, MD, Dietrich W. Beelen

Blood (2018) 132 (Supplement 1): 3413.

https://doi.org/10.1182/blood-2018-99-116785

Published: 2018

Journal Articles

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Debora Queiros, MSc, Susanne Luther-Wolf, Eva M Weissinger, MD, Arnold Ganser, MD

Blood (2018) 132 (Supplement 1): 3327.

https://doi.org/10.1182/blood-2018-99-110779

Published: 2018

Journal Articles

Differences of Human Cytomegalovirus Strains in Recipients of Allogeneic Hematopoietic Stem Cells before and after Transplantation

Michael V Demin, bachelor, Dmitry S. Tikhomirov, PhD, Bella V. Biderman, PhD, Olga A. Glinshchikova, PhD, Tatiana A. Tupoleva, MD PhD, Andrey Sudarikov, PhD, Feliks F. Filatov, Sc. D, Tatiana V. Gaponova, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5510.

https://doi.org/10.1182/blood.V130.Suppl_1.5510.5510

Published: 2017

Journal Articles

The Impact of Cytomegalovirus (CMV) Reactivation on Clinical Course and Immunomodulatory Effect in Children with Immune-Thrombocytopenia (ITP)

Mohsen Saleh Elalfy, MD PhD, Iman Ragab, Marwa Reda, Mohamed Sallam, Hoda Ezz El-Arab, Omneya Shafei, Alaa Mousa

Blood (2017) 130 (Supplement 1): 1045.

https://doi.org/10.1182/blood.V130.Suppl_1.1045.1045

Published: 2017

Journal Articles

Dissecting Human Antibody Responses: Useful, Basic, and Surprising Findings

Antonio Lanzavecchia, MD

Blood (2017) 130 (Supplement 1): SCI-49.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-49.SCI-49

Published: 2017

Journal Articles

Pro-Inflammatory State of MGUS and Myeloma Patients Presenting with a Monoclonal Immunoglobulin Specific for an Infectious Pathogen

Adrien Bosseboeuf, PhD, Delphine Feron, PhD, Sophie Allain-Maillet, Nicolas Mennesson, Cathy Charlier, PhD, Anne Tallet, Francois Girodon, MD PhD, Laurent Garderet, MD PhD, Cédric Rossi, MD, Denis Caillot, MD, Philippe Moreau, MDPhD, Pierre Weigel, PhD, Eric Piver, PhD, Edith Bigot-Corbel, PhD, Jean Harb, PhD, Sylvie Hermouet, MDPhD

Blood (2017) 130 (Supplement 1): 3048.

https://doi.org/10.1182/blood.V130.Suppl_1.3048.3048

Published: 2017

Journal Articles

Comparative Analysis of Serological Markers of Herpes Viruses and Hypergammaglobulinaemia in Patients with Angioimmunoblastic T-Cell Lymphoma

Natalia G. Chernova, MD PhD, Dmitry S. Tikhomirov, PhD, Natalia P. Soboleva, MD, Yulia Sidorova, MD PhD, Marina N. Sinitsyna, MD, Tatiana A. Tupoleva, MD PhD, Valentina N. Dvyrnik, MD PhD, Eugene E. Zvonkov, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5180.

https://doi.org/10.1182/blood.V130.Suppl_1.5180.5180

Published: 2017

Journal Articles

Most Closely HLA-Matched Third Party Allogeneic CMV Specific T-Cells Generated Using the Cytokine Capture System for the Treatment of CMV Infections after Allogeneic Stem Cell Transplantation

Blood (2016) 128 (22): 4547.

https://doi.org/10.1182/blood.V128.22.4547.4547

Published: 2016

Journal Articles

CAR T Cells Targeted with a High Affinity Scfv Against the HCMV Glycoprotein Gb As Adoptive T Cell Therapy after Hematopoietic Stem Cell Transplantation

Renata Stripecke, PhD, Laura Gerasch, Sebastian Theobald, Bala Sai Sundarasetty, PhD, Maksim Mamonkin, PhD, Thomas Shum, BS, Cliona M. Rooney, PhD

Blood (2016) 128 (22): 5721.

https://doi.org/10.1182/blood.V128.22.5721.5721

Published: 2016

Journal Articles

Peptides Derived from the CMV Proteome Mimic Unique Stem Cell Transplant Recipient Specific Peptides: Possible Role in Eliciting a Pro-Gvh T Cell Response

Charles E. Hall, MS, Max Jameson-Lee, PhD, Abdelrhman Elnasseh, Vishal Koparde, PhD, Allison F. Scalora, MS, Catherine H. Roberts, PhD, Nihar U. Sheth, MS, Myrna G. Serrano, PhD, Daniel Nixon, DO, PhD, Harold M. Chung, MD, Oveimar A. De la Cruz, MD, William B. Clark, MD, John M. McCarty, MD, Gregory A. Buck, PhD, Michael C. Neale, PhD, Amir A. Toor, MD

Blood (2015) 126 (23): 4285.

https://doi.org/10.1182/blood.V126.23.4285.4285

Published: 2015

NARROW

Evaluation of Virus-Specific T Cell Responses in Patients Affected with Myeloproliferative Neoplasms Treated with Ruxolitinib

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Repertoire of Cytomegalovirus-Specific T Cells Is Focused on the Immunodominant Epitopes in Fixed Hierarchy Dependent on HLA Genotype of the Donor

Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR)

Reduced Expression of the CD94/NKG2C NK Cell Receptor in Chronic Lymphocytic Leukemia (CLL) and CLL-like Monoclonal B-Cell Lymphocytosis (MBL)

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

Comparing Costs Associated to Letermovir Prophylaxis Vs Ganciclovir Pre-Emptive Therapy in HCMV-Seropositive Patients Who Undergone to Hemopoietic Stem Cells Transplantation

Cytomegalovirus Infection in Bone Marrow-Derived Mesenchymal Stem Cells: Implications for Functions and Exploration of Relevant Mechanisms

Poor NKG2C+ Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

First-Line Therapy with Donor Derived HCMV-Specific T Cells Reduce Persistent HCMV Infection after Allogenic Stem Cell Transplantation

Early Cytomegalovirus Reactivation and Donor Constellation Reduce Early and Late Relapse Incidence of Acute Myeloid Leukemia in a Long-Term Study

NKG2C + CD57 + Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT

Differences of Human Cytomegalovirus Strains in Recipients of Allogeneic Hematopoietic Stem Cells before and after Transplantation

The Impact of Cytomegalovirus (CMV) Reactivation on Clinical Course and Immunomodulatory Effect in Children with Immune-Thrombocytopenia (ITP)

Dissecting Human Antibody Responses: Useful, Basic, and Surprising Findings

Pro-Inflammatory State of MGUS and Myeloma Patients Presenting with a Monoclonal Immunoglobulin Specific for an Infectious Pathogen

Comparative Analysis of Serological Markers of Herpes Viruses and Hypergammaglobulinaemia in Patients with Angioimmunoblastic T-Cell Lymphoma

Most Closely HLA-Matched Third Party Allogeneic CMV Specific T-Cells Generated Using the Cytokine Capture System for the Treatment of CMV Infections after Allogeneic Stem Cell Transplantation

CAR T Cells Targeted with a High Affinity Scfv Against the HCMV Glycoprotein Gb As Adoptive T Cell Therapy after Hematopoietic Stem Cell Transplantation

Peptides Derived from the CMV Proteome Mimic Unique Stem Cell Transplant Recipient Specific Peptides: Possible Role in Eliciting a Pro-Gvh T Cell Response

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only